Drug News (Medindia)

Update on COVID-19 Cases in India

India broke its own 24-hour record today, adding 6,088 coronavirus cases in single day as the total number of novel Coronavirus cases touched 1,18,447.

Eating Fish Reduces Risk of Heart Disease: Study

Consuming omega 3 essentially through fish, or supplements containing these fatty acids can modulate lipoproteins and can decrease the risk of cardiovascular disease, reveals a new study.

Birth Control Pills Influence the Love Hormone: Study

New study from Aarhus University has shown that women who take birth control pills have a much higher level of the hormone oxytocin, also called the love hormone, in their blood compared to non-users.

Durvalumab Combo Improved Survival in Mesothelioma

Phase 2 trial PrE0505 selected for oral presentation at ASCO 2020; data signals the combination of Durvalumab with pemetrexed and cisplatin could advance to a randomized phase 3 study.

COVID-19: Hydroxychloroquine Trial Begins in the UK

COVID-19 vaccine trial with two antimalarial drugs - chloroquine and hydroxychloroquine has begun in the UK's Brighton and Oxford. The trial is open to anyone delivering direct care to coronavirus patients in the UK.

Emergency COVID-19 Vaccine Could be Ready by 2021

Emergency vaccine for coronavirus (COVID-19) can be ready by next January or February. mRNA vaccines represent a promising alternative to conventional vaccine approaches because of their high potency, capacity for rapid development and potential for low-cost manufacture and safe administration.

Exercise Improves Memory and Delays Alzheimer's

Aerobic workouts help improve your memory by boosting the blood flow to your brain. Also, regular exercise can play a small role in delaying or reducing the risk of Alzheimer's disease.

Oxford Vaccine Shows No Signs of Worsening COVID-19 Symptoms

Oxford University has reported positive findings from preclinical animal studies of its potential COVID-19 vaccine ChAdOx1, which involved nine rhesus macaques. However, results from human clinical trials are expected next month.